You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Investigational Drug Information for Linifanib


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Linifanib?

Linifanib is an investigational drug.

There have been 12 clinical trials for Linifanib. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2010.

The most common disease conditions in clinical trials are Neoplasms, Carcinoma, Hepatocellular, and Carcinoma. The leading clinical trial sponsors are Abbott, AbbVie, and Vanderbilt-Ingram Cancer Center.

Recent Clinical Trials for Linifanib
TitleSponsorPhase
Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular CarcinomaSir Salimullah Medical College Mitford HospitalN/A
Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the EndometriosisBioGene Pharmaceutical Ltd.Phase 1/Phase 2
A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid TumorsAbbottPhase 1

See all Linifanib clinical trials

Clinical Trial Summary for Linifanib

Top disease conditions for Linifanib
Top clinical trial sponsors for Linifanib

See all Linifanib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.